Tanvex BioPharma (TPE:6541) Net Issuance of Debt : NT$-375.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Tanvex BioPharma Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Tanvex BioPharma's net issuance of debt for the three months ended in Mar. 2025 was NT$0.00 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-375.00 Mil.

Tanvex BioPharma Net Issuance of Debt Historical Data

The historical data trend for Tanvex BioPharma's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tanvex BioPharma Net Issuance of Debt Chart

Tanvex BioPharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Issuance of Debt

Get a 7-Day Free Trial

94.87

Tanvex BioPharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Issuance of Debt	Get a 7-Day Free Trial															375.00	-375.00	-	-	-

Tanvex BioPharma Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-375.00 Mil.

Tanvex BioPharma Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Tanvex BioPharma's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Tanvex BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tanvex BioPharma Inc (TPE:6541) » Definitions » Net Issuance of Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 376, Ren\'ai Road, Section 4, 13th Floor-1, Da\'an District, Taipei, TWN, 106

Website

https://www.tanvex.com

Tanvex BioPharma Inc is a biopharmaceutical company. It is engaged in the research, development, manufacture, and sale of biosimilar products and contract development and manufacturing of biological medicine. The company's products are used to cure diseases such as Neutropenia, Breast Cancer, Metastatic Colorectal Cancer, and others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from the United States.

Tanvex BioPharma Headlines

No Headlines